Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Assets (2021 - 2025)

Historic Return on Assets for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to 0.04%.

  • Xeris Biopharma Holdings' Return on Assets rose 1500.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.17% for FY2024, which is 200.0% up from last year.
  • According to the latest figures from Q3 2025, Xeris Biopharma Holdings' Return on Assets is 0.04%, which was up 1500.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Return on Assets registered a high of 0.04% during Q3 2025, and its lowest value of 0.56% during Q4 2021.
  • For the 5-year period, Xeris Biopharma Holdings' Return on Assets averaged around 0.25%, with its median value being 0.19% (2024).
  • As far as peak fluctuations go, Xeris Biopharma Holdings' Return on Assets soared by 2700bps in 2022, and later crashed by -100bps in 2024.
  • Quarter analysis of 5 years shows Xeris Biopharma Holdings' Return on Assets stood at 0.56% in 2021, then surged by 48bps to 0.29% in 2022, then soared by 35bps to 0.19% in 2023, then rose by 11bps to 0.17% in 2024, then soared by 74bps to 0.04% in 2025.
  • Its Return on Assets was 0.04% in Q3 2025, compared to 0.1% in Q2 2025 and 0.14% in Q1 2025.